$SID

NATIONAL STEEL CO (SID): Financial results for Q2 2026

NATIONAL STEEL CO (SID) furnished an SEC Form 6-K — earnings release. Yes _______ No ___X____ 2Q26 EARNINGS RELEASE August 12, 2026 2Q26 RESULTS São Paulo, August 12, 2026 - Companhia Siderúrgica Nacional (“CSN”) (B3: CSNA3; NYSE: SID) today reports its results for the second quarter of 2026 (2Q26) , presented in Brazilian reais. The Company’s cons

Original reporting
Published Aug 13, 2026, 5:53 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 6:16 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$SID
Bearish
high confidence
Mentioned
$SID
Relevance
7/10
alphai data visualization · based on SEC EDGAR 6-K
Decision brief

The 30-second read

$SIDBearishMed
01

Why it matters

The earnings miss may trigger short‑term selling, but the underlying revenue growth and adjusted EBITDA increase suggest operational resilience.

02

Market read

Primary earnings disclosure for a major steel producer; material numbers likely to move the stock.

03

What to watch

Equity income from MRS and potential FX hedging improvements could mitigate future losses.

Relevance 7/10Novelty 8/10Timing: after-hours release Aug 12, 2026

Background

Companhia Siderúrgica Nacional (CSN) filed a Form 6‑K with its Q2 2026 results, reporting revenue up 6.6% QoQ but a net loss due to higher financial expenses and FX effects.

Company-level read

Ticker impact

$SIDBearishHigh confidence
Context

Q2 2026 earnings release shows net loss of R$773.1M despite revenue growth, indicating short-term downside pressure.

Expected impact

Potential near-term decline of 3‑5% as investors digest loss and higher costs.

Evidence & confidence

The primary disclosure of a net loss and widening loss YoY is material and new, likely prompting traders to adjust positions.

Market effects

Steel sector may see broader pressure as a major Brazilian producer reports losses, highlighting cost and FX headwinds.

Brazilian market could see modest pullback in materials stocks following CSN's results.

Limited global impact; primarily relevant to investors in emerging market steel exposure.

Counterpoint

Despite the loss, revenue growth and stable EBITDA margin could support a longer‑term rebound if cost pressures ease.

Key entities

  • Companhia Siderúrgica Nacional

    Brazilian steel producer listed on NYSE as SID.

Related articles

$DELLHighAI 8/10

Dell Technologies Inc. (DELL) Hit a 52 Week High, Can the Run Continue?

Dell Technologies (DELL) shares hit a 52-week high of $530.78, up 18% in the past month and 310.2% year-to-date. The company reported EPS of $7.04 in its last earnings report, beating estimates. Analysts expect earnings of $20.48 per share for the current fiscal year. Dell has a Zacks Rank of #1 (Strong Buy) and a VGM Score of B. HP Inc. (HPQ) is also highlighted as a strong performer in the industry.

$NJRMed

New Jersey Resources (NJR) Turns Last Year’s Loss Into A Guidance Raise

New Jersey Resources (NJR) reported Q3 2026 net income of $9.7M, reversing a $15.1M loss from Q3 2025. Nine-month earnings rose to $351.1M. Management raised FY2026 guidance to $3.52-$3.62 per share. Growth came from Storage, Transportation, and Energy Services, while Clean Energy Ventures narrowed losses. NJR's utility segment faced depreciation costs. Hedge fund interest slightly declined, and short interest is 4.86% of float.

$LGNHighAI 8/10

Legence (LGN) Doubled Revenue While Margins And Losses Widened

Legence Corp. (NASDAQ:LGN) reported Q2 revenue of $1.26B, up 110.7% YoY, with adjusted EBITDA rising 114.1% to $154.6M. Backlog reached $5.67B, up from $2.77B YoY. However, gross margin fell to 17.4% from 21.5%, and net loss widened to $27.8M. The company raised full-year revenue guidance to $4.7B-$4.8B and adjusted EBITDA to $565M-$585M.

$LGNDHighAI 8/10

Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book

Ligand Pharmaceuticals (LGND) reported Q2 2026 revenue of $63.7M, up 32% YoY, driven by royalty revenue growth. The company acquired XOMA Royalty, doubling its royalty portfolio and adding $700M in convertible debt. Ligand raised its full-year adjusted earnings guidance, but expenses increased due to the acquisition and other costs. The stock trades at a forward P/E of 25.19.

$VSECMedAI 8/10

A Record Quarter Raises The Stakes For VSE Corp. (VSEC)

VSE Corporation (VSEC) reported Q2 revenue of $449.1M, up 65% YoY, with organic growth of 14%. Adjusted EBITDA rose to $86.0M, with a margin of 19.2%. The company completed two major acquisitions, raising full-year guidance. Debt increased to $966.7M, and free cash flow was negative $50.0M for H1 2026. The stock trades at 25x forward earnings.